» Articles » PMID: 17331079

Spectrum of Mutations in the CFTR Gene in Cystic Fibrosis Patients of Spanish Ancestry

Overview
Journal Ann Hum Genet
Date 2007 Mar 3
PMID 17331079
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed 1,954 Spanish cystic fibrosis (CF) alleles in order to define the molecular spectrum of mutations in the CFTR gene in Spanish CF patients. Commercial panels showed a limited detection power, leading to the identification of only 76% of alleles. Two scanning techniques, denaturing gradient gel electrophoresis (DGGE) and single strand conformation polymorphism/hetroduplex (SSCP/HD), were carried out to detect CFTR sequence changes. In addition, intragenic markers IVS8CA, IVS8-6(T)n and IVS17bTA were also analyzed. Twelve mutations showed frequencies above 1%, p.F508del being the most frequent mutation (51%). We found that eighteen mutations need to be studied to achieve a detection level of 80%. Fifty-one mutations (42%) were observed once. In total, 121 disease-causing mutations were identified, accounting for 96% (1,877 out of 1,954) of CF alleles. Specific geographic distributions for the most common mutations, p.F508del, p.G542X, c.1811 + 1.6kbA > G and c.1609delCA, were confirmed. Furthermore, two other relatively common mutations (p.V232D and c.2789 + 5G > A) showed uneven geographic distributions. This updated information on the spectrum of CF mutations in Spain will be useful for improving genetic testing, as well as to facilitate counselling in people of Spanish ancestry. In addition, this study contributes to defining the molecular spectrum of CF in Europe, and corroborates the high molecular mutation heterogeneity of Mediterranean populations.

Citing Articles

Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics.

Yildiz C, Selcuk Balci M, Karabulut S, Baser Z, Kalyoncu M, Metin Cakar N Pediatr Pulmonol. 2024; 59(12):3540-3549.

PMID: 39291770 PMC: 11600995. DOI: 10.1002/ppul.27249.


Diagnosis of cystic fibrosis: a high heterogeneity of symptoms and genotypes in a Brazil population.

Meneses D, Dos Santos F, Botelho A, Bispo L, Matos C, Propheta V BMC Pediatr. 2024; 24(1):422.

PMID: 38956483 PMC: 11218259. DOI: 10.1186/s12887-024-04891-z.


Identification and structural analysis for the first mutation in the cystic fibrosis transmembrane conductance regulator protein in Iran: case report and developmental insight using microsatellite markers.

Hosseini Nami A, Kabiri M, Zafarghandi Motlagh F, Shirzadeh T, Bagherian H, Zeinali R Ther Adv Respir Dis. 2024; 18:17534666241253990.

PMID: 38904297 PMC: 11193346. DOI: 10.1177/17534666241253990.


Elevated Prostaglandin E Synthesis Is Associated with Clinical and Radiological Disease Severity in Cystic Fibrosis.

Gartner S, Roca-Ferrer J, Fernandez-Alvarez P, Lima I, Rovira-Amigo S, Garcia-Arumi E J Clin Med. 2024; 13(7).

PMID: 38610815 PMC: 11012863. DOI: 10.3390/jcm13072050.


Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction.

Zacarias S, Batista M, Ramalho S, Victor B, Farinha C Int J Mol Sci. 2023; 24(4).

PMID: 36834620 PMC: 9961391. DOI: 10.3390/ijms24043211.